05 Jun ACIP Dosing Recommendations – MenB Vaccines
Pfizer reminds members that as the back-to-school immunization season approaches please be aware that after the October 2024 ACIP meeting, all MenB vaccines now align to the same recommended schedule (2 doses at 0 and 6 months when used as a 2-dose series) for healthy adolescents and young adults aged 16 to 23 years, based on shared clinical decision-making. Log in to read the full article.